ClinVar Miner

Submissions for variant NM_004064.5(CDKN1B):c.31C>T (p.Pro11Ser)

gnomAD frequency: 0.00004  dbSNP: rs779193240
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000466839 SCV000541765 uncertain significance Multiple endocrine neoplasia type 4 2024-02-01 criteria provided, single submitter clinical testing This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 11 of the CDKN1B protein (p.Pro11Ser). This variant is present in population databases (rs779193240, gnomAD 0.007%). This missense change has been observed in individual(s) with prostate cancer (PMID: 17372254). ClinVar contains an entry for this variant (Variation ID: 404268). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV000567002 SCV000673205 likely benign Hereditary cancer-predisposing syndrome 2023-01-05 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
GeneDx RCV003128801 SCV003805808 uncertain significance not provided 2022-08-26 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with prostate cancer (Cybulski et al., 2007); This variant is associated with the following publications: (PMID: 17372254)
Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University RCV003153576 SCV003843619 likely pathogenic Ovarian cancer 2022-01-01 criteria provided, single submitter clinical testing
Baylor Genetics RCV000466839 SCV005060218 uncertain significance Multiple endocrine neoplasia type 4 2024-02-06 criteria provided, single submitter clinical testing
Zotz-Klimas Genetics Lab, MVZ Zotz Klimas RCV000466839 SCV004041657 uncertain significance Multiple endocrine neoplasia type 4 2023-10-09 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.